XERIS BIOPHARMA HOLDINGS INC (XERS) Institutional Ownership and Insiders Activity
XERIS BIOPHARMA HOLDINGS INC (XERS) is widely held by institutional investors, with 233 firms reporting positions valued at approximately $851.74M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $115.04M in XERS holdings in its latest filing.
Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
233
Total Reported Value
$851.74M
Largest Holder
Blackrock, Inc.
Largest Position
$115.04M
Insider Transactions (90d)
12
Latest Filing Quarter
Q2 2026
New Institutional Positions
41
Funds Exiting Positions
38
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$115.04M
- D. E. Shaw & Co., Inc.$61.81M
- Vanguard Capital Management Llc$58.13M
- State Street Corp$38.19M
- Geode Capital Management, Llc$37.37M
Related XERS Institutional Insights:
- XERS 13F Institutional Holders
- XERS Top Institutional Shareholders
- XERS Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- XERS Insider Trading & SEC Form 4 Activity
- XERS Articles
- Top Institutional Investor Stock Rankings